4.6 Article

Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J. L. Murray et al.

Summary: Antimicrobial resistance (AMR) poses a significant threat to global human health, and this study provides the most comprehensive estimates of AMR burden to date. By estimating deaths and disability-adjusted life-years (DALYs) associated with bacterial AMR in 204 countries and territories in 2019, the study highlights the impact of resistance and the leading pathogen-drug combinations contributing to it.

LANCET (2022)

Editorial Material Infectious Diseases

Infectious Diseases of Poverty: progress achieved during the decade gone and perspectives for the future

Xiao-Nong Zhou

INFECTIOUS DISEASES OF POVERTY (2022)

Article Infectious Diseases

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

Matteo Bassetti et al.

Summary: The study assessed the efficacy and safety of cefiderocol versus best available therapy in the treatment of patients with carbapenem-resistant Gram-negative infections. Cefiderocol showed similar clinical and microbiological efficacy to best available therapy in this heterogeneous patient population with infections caused by carbapenem-resistant Gram-negative bacteria, suggesting it as an option for the treatment of carbapenem-resistant infections in patients with limited treatment options.

LANCET INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

The incidence, mortality and renal outcomes of acute kidney injury in patients with suspected infection at the emergency department

Meriem Khairoun et al.

Summary: AKI is common among patients with suspected infection in the emergency department and is significantly associated with 30-day mortality and renal function decline one year after the AKI episode.

PLOS ONE (2021)

Article Infectious Diseases

Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic

Bernardo A. Martinez-Guerra et al.

Summary: The study found a high frequency of empiric antibiotic treatment in severe COVID-19 patients upon admission, with VAP and BSI being the most common hospital-acquired infections, caused by Enterobacteriaceae and coagulase negative staphylococci, respectively.

ANTIBIOTICS-BASEL (2021)

Article Public, Environmental & Occupational Health

Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilities

S. Zhao et al.

Summary: The incidence of CPO in Scotland is low but increasing, mainly caused by Enterobacterales with VIM and NDM being the most common carbapenemases. Mortality rate is associated with age, specific pathogens, and systemic infection or organ failure.

JOURNAL OF HOSPITAL INFECTION (2021)

Article Medicine, General & Internal

Calculating the sample size required for developing a clinical prediction model

Richard D. Riley et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Infectious Diseases

Factors associated with mortality in Infections caused by Carbapenem-resistant Enterobacteriaceae

Sandra Gualtero et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2020)

Review Medicine, General & Internal

Sepsis associated acute kidney injury

Jason T. Poston et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Microbiology

Antimicrobial Resistance: a One Health Perspective

Scott A. McEwen et al.

MICROBIOLOGY SPECTRUM (2018)

Article Public, Environmental & Occupational Health

Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis

Philipp P. Kohler et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2017)

Article Infectious Diseases

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States

S. M. Bartsch et al.

CLINICAL MICROBIOLOGY AND INFECTION (2017)

Article Infectious Diseases

Mortality due to blaKPC Klebsiella pneumoniae bacteraemia

Yedidah Fraenkel-Wandel et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

Article Public, Environmental & Occupational Health

Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia

Yu-long Zheng et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2013)

Article Infectious Diseases

Validation of carbapenemase and extended-spectrum -lactamase multiplex endpoint PCR assays according to ISO 15189

P. Bogaerts et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)

Article Infectious Diseases

Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections

D. Ben-David et al.

CLINICAL MICROBIOLOGY AND INFECTION (2012)

Article Immunology

Global Spread of Carbapenemase-producing Enterobacteriaceae

Patrice Nordmann et al.

EMERGING INFECTIOUS DISEASES (2011)

Article Public, Environmental & Occupational Health

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

Teresa C. Horan et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2008)

Article Medicine, General & Internal

Carbapenem-Resistant Enterobacteriaceae

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)